GNAO1 and Encephalopathy: To sum up, the study presented here sweeps from the understanding, at the molecular and even atomistic level, of the core biochemical dysfunctions seen in the three most frequent GNAO1 encephalopathy mutations to assay establishment and screening for drug candidates to rescue this dysfunction, followed by the candidate validation in biochemical and cellular models.